Table 3.
Variable | OR | 95%CI | p Value |
---|---|---|---|
Demographic | |||
Age, years | 1.02 | 1.01 - 1.03 | 0.042 |
Female | 0.68 | 0.48 - 0.95 | 0.025 |
BMI, kg/m2 | 0.98 | 0.94 - 1.02 | 0.256 |
Cardiac data | |||
Paroxysmal AF | 1.74 | 1.01 - 2.98 | 0.044 |
CAD | 1.76 | 0.93 - 3.31 | 0.080 |
Prior AMI | 1.41 | 0.98 - 2.01 | 0.061 |
Comorbidities | |||
Hypertension | 1.12 | 0.87 - 1.43 | 0.387 |
Diabetes | 1.73 | 1.23 - 2.41 | 0.001 |
Dyslipidemia | 1.21 | 0.83 - 1.76 | 0.326 |
COPD | 0.99 | 0.77 - 1.27 | 0.931 |
Current smokers | 1.27 | 0.99 - 1.64 | 0.064 |
PVD | 1.03 | 0.77 - 1.37 | 0.836 |
Preop CVA | 1.41 | 0.79 - 2.51 | 0.249 |
CRF | 1.17 | 0.29 - 4.70 | 0.826 |
Other data | |||
Creatinine (basal), mg/dL | 1.20 | 0.89 - 1.62 | 0.216 |
Hb, g/dL | 0.95 | 0.88 - 1.03 | 0.210 |
FEV1 < 80% | 0.74 | 0.58 - 0.96 | 0.025 |
Cancer characteristics | |||
Right Lobectomy | 1.16 | 0.91 - 1.48 | 0.235 |
Neoadjuvant chemotherapy | 1.04 | 0.62 - 1.75 | 0.884 |
Stage UICCa | 1.96 | 1.52 - 2.53 | < 0.001 |
Histologyb | 0.91 | 0.71 - 1.16 | 0.452 |
Postoperative Data | |||
Inotropes | 1.79 | 0.98 - 3.29 | 0.060 |
Blood transfusion | 1.51 | 1.02 - 2.22 | 0.037 |
FBS | 1.11 | 0.69 - 1.78 | 0.658 |
Postop AMI | 1.98 | 0.28 - 14.18 | 0.493 |
Postop CVA | 3.26 | 1.45 - 7.35 | 0.004 |
AKI | 1.17 | 0.62 - 2.20 | 0.632 |
POPAF | 1.41 | 0.95 - 2.09 | 0.087 |
a Classes I and II vs. classes III and IV (class I and II as a reference group)
b Adenocarcinoma vs. others carcinoma (others as a reference group)
AKI acute kidney injury, AF atrial fibrillation, AMI acute myocardial infarction, BMI body mass index, CAD coronary artery disease, COPD chronic obstructive pulmonary disease, CRF chronic renal failure, CVA cerebrovascular accident, FBS fibrobronchoscopy, FEV1 forced expiratory volume in 1 second, Hb hemoglobin, POPAF postoperative atrial fibrillation, PVD peripheral vascular disease, UICC Union International Contre le Cancer.